- Home
- DGICA vs INMD Comparison
DGICA vs INMD Comparison
Compare DGICA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DGICA | INMD |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 714.2M | 854.5M |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DGICA | INMD |
|---|---|---|
| Price | $18.85 | $14.93 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $19.00 | $17.33 |
| AVG Volume (30 Days) | 94.6K | ★ 396.9K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $978,014,322.00 | N/A |
| Revenue This Year | $2.26 | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ $7.82 | $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.11 | $12.72 |
| 52 Week High | $21.06 | $16.74 |
Technical Indicators
Market Signals| Indicator | DGICA | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.01 | 40.17 |
| Support Level | $18.12 | $13.27 |
| Resistance Level | $19.42 | $14.76 |
| Average True Range (ATR) | 0.46 | 0.18 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 46.58 | 4.08 |
Price Performance
Historical ComparisonAbout DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.